Russell Investments Group
TARA icon

Russell Investments Group’s Protara Therapeutics TARA Stock Holding History

Russell Investments Group’s Portfolio TARA Stock Details TARA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$109K Buy
28,469
+25,793
+964% +$123K ﹤0.01% 3426
2026
Q1 		$13.9K Hold
2,676
– – ﹤0.01% 3707
2025
Q4 		$14.3K Hold
2,676
– – ﹤0.01% 3708
2025
Q3 		$11.6K Buy
+2,676
New +$8.66K ﹤0.01% 3755

Other funds holding TARA

JT
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $164M AUM 542.31% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Blackstone Inc
Blackstone Inc New York $32.9B AUM 23.66% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
SCM
Sio Capital Management New York $604M AUM 96.57% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $366M AUM 474.6% 1-Year Est. Return
IHAM
Integral Health Asset Management New York $2.53B AUM 154.61% 1-Year Est. Return

Russell Investments Group's TARA Position: Q2 2026 in Review

Russell Investments Group increased its Protara Therapeutics (TARA) stake by 964% in Q2 2026, buying an estimated $123K and bringing the position to 28,469 shares worth $109K. The position accounts for ﹤0.01% of the portfolio, ranked #3426.

Russell Investments Group first reported a position in TARA in Q3 2025 and has held it in 4 quarters since. 120 funds tracked by Wall St. Rank hold TARA as of Q2 2026.

  • Russell Investments Group held 28,469 shares of Protara Therapeutics worth $109K as of Q2 2026.
  • Russell Investments Group bought 25,793 Protara Therapeutics shares in Q2 2026, an estimated $123K.
  • Protara Therapeutics made up ﹤0.01% of Russell Investments Group's portfolio in Q2 2026, its #3426 holding.
  • Russell Investments Group first reported a position in Protara Therapeutics in Q3 2025 and has held it in 4 quarters since.
  • 120 funds tracked by Wall St. Rank held Protara Therapeutics as of Q2 2026.

Based on Russell Investments Group's 13F filing for Q2 2026, filed 6 Aug 2026.